Aggressive treatment and prophylaxis. US and MCUG for all children aged <2 years. 99m Tc–DMSA scan in high-grade reflux [3] Urinary tract infection (UTI) is the most common serious bacterial ...

We decided a treatment of 3 days simulating the guidelines of antibiotic treatment in PCUTI ... of Cys as there were no adverse events at all. Prophylaxis of Cys seems to be a promising option ...

Key themes and highlights from ESCMID Global 2025 to support antimicrobial stewardship and best practice in infectious ...

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...

Four tests that could allow people with urinary tract infections to receive the correct course of antibiotics more quickly are on course to be used by NHS hospitals, provided further research ...

Prevalence of UTIs in Indian population is estimated to be around 33%. Men have less than 15% chance of developing this ...

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.

Researchers at NYU Langone’s Resilience, Intersectional Stigma, and Empowerment Lab explore barriers to pre-exposure prophylaxis.

While clinical pharmacists can receive training in AMS, their role in urology and surgical prophylaxis remains limited, with only a few hospitals integrating pharmacist-led interventions such as ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.